Comorbid health conditions in people with attention-deficit/hyperactivity disorders: An umbrella review of systematic reviews and meta-analyses

J Kang, H Lee, S Kim, HJ Kim, H Lee, R Kwon… - Asian Journal of …, 2024 - Elsevier
Background We aimed to systematically review meta-analyses on the link between attention-
deficit/hyperactivity disorder (ADHD) and a broad range of psychiatric, physical, and …

[HTML][HTML] Treatments in the pipeline for attention-deficit/hyperactivity disorder (ADHD) in adults

GF Veronesi, A Gabellone, A Tomlinson… - Neuroscience & …, 2024 - Elsevier
To provide an overview of treatments in the pipeline for adults with attention-
deficit/hyperactivity disorder (ADHD), we searched https://clinicaltrials. gov/and and …

Worldwide prevalence and disability from mental disorders across childhood and adolescence: evidence from the global burden of disease study

C Kieling, C Buchweitz, A Caye, J Silvani… - JAMA …, 2024 - jamanetwork.com
Importance The period from childhood to early adulthood involves increased susceptibility to
the onset of mental disorders, with implications for policy making that may be better …

ADHD medications use and risk of mortality and unintentional injuries: a population-based cohort study

HM Vasiliadis, C Lunghi, E Rahme, L Rochette… - Translational …, 2024 - nature.com
We assessed the association between the use of medications for attention-
deficit/hyperactivity disorder (ADHD) and the risk of all-cause mortality and unintentional …

Comparative efficacy and acceptability of pharmacological, psychological, and neurostimulatory interventions for ADHD in adults: a systematic review and component …

EG Ostinelli, M Schulze, C Zangani, LC Farhat… - The Lancet …, 2025 - thelancet.com
Background The comparative benefits and harms of available interventions for ADHD in
adults remain unclear. We aimed to address these important knowledge gaps. Methods In …

[HTML][HTML] Add-On Bifidobacterium Bifidum Supplement in Children with Attention-Deficit/Hyperactivity Disorder: A 12-Week Randomized Double-Blind Placebo …

LJ Wang, CS Tsai, WJ Chou, HC Kuo, YH Huang… - Nutrients, 2024 - mdpi.com
We conducted a 12-week randomized double-blind placebo-controlled clinical trial to
investigate the potential impact of Bifidobacterium bifidum (Bf-688) supplementation on …

From neurons to brain networks, pharmacodynamics of stimulant medication for ADHD

V Parlatini, A Bellato, D Murphy, S Cortese - Neuroscience & Biobehavioral …, 2024 - Elsevier
Stimulants represent the first line pharmacological treatment for attention-deficit/hyperactivity
disorder (ADHD) and are among the most prescribed psychopharmacological treatments …

Electronic health records for research on attention-deficit/hyperactivity disorder pharmacotherapy: A comprehensive review

S Roy, L Arturi, V Parlatini, S Cortese - Journal of Child and …, 2024 - liebertpub.com
Objectives: Randomized controlled trials (RCTs) have shown that attention-
deficit/hyperactivity disorder (ADHD) medications significantly reduce symptomatology at a …

Relationships between screen time and childhood attention deficit hyperactivity disorder: a Mendelian randomization study

Z Meng, B Ao, W Wang, T Niu, Y Chen, X Ma… - Frontiers in …, 2024 - frontiersin.org
Background In previous observational studies and meta-analyses, childhood attention deficit
hyperactivity disorder (ADHD) is found to have a significant association with screen time …

Global burden of ADHD medication-associated cardiovascular disease, 1967–2023: A comparative analysis using the WHO pharmacovigilance database

H Cho, K Lee, YD Jeong, R Udeh, KP Acharya… - Asian Journal of …, 2024 - Elsevier
Background Despite the widespread use of attention-deficit hyperactivity disorder (ADHD)
medications and their known sympathomimetic effects on the cardiovascular system …